Screening compound: InChI=1S/C22H30F2N2O2/c23-19-13-17(14-20(24)15-19)16-25-8-3-18(4-9-25)21(27)26-10-6-22(7-11-26)5-1-2-12-28-22/h13-15,18H,1-12,16H2

Screening compound: InChI=1S/C22H30F2N2O2/c23-19-13-17(14-20(24)15-19)16-25-8-3-18(4-9-25)21(27)26-10-6-22(7-11-26)5-1-2-12-28-22/h13-15,18H,1-12,16H2
Screening compound: InChI=1S/C22H30F2N2O2/c23-19-13-17(14-20(24)15-19)16-25-8-3-18(4-9-25)21(27)26-10-6-22(7-11-26)5-1-2-12-28-22/h13-15,18H,1-12,16H2 alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C22H30F2N2O2/c23-19-13-17(14-20(24)15-19)16-25-8-3-18(4-9-25)21(27)26-10-6-22(7-11-26)5-1-2-12-28-22/h13-15,18H,1-12,16H2

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

T500-1874

Molecular Formula

C22H30F2N2O2 (C22 H30 F2 N2 O2)

Compound Name

9-{1-[(3,5-difluorophenyl)methyl]piperidine-4-carbonyl}-1-oxa-9-azaspiro[5.5]undecane

IUPAC name

9-{1-[(35-difluorophenyl)methyl]piperidine-4-carbonyl}-1-oxa-9-azaspiro[5.5]undecane

SMILES

O=C(C1CCN(Cc2cc(F)cc(F)c2)CC1)N(CC1)CCC11OCCCC1

InChI

InChI=1S/C22H30F2N2O2/c23-19-13-17(14-20(24)15-19)16-25-8-3-18(4-9-25)21(27)26-10-6-22(7-11-26)5-1-2-12-28-22/h13-15,18H,1-12,16H2

InChI Key

AZFZVVZBRRSWDP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD32262259

InChI=1S/C22H30F2N2O2/c23-19-13-17(14-20(24)15-19)16-25-8-3-18(4-9-25)21(27)26-10-6-22(7-11-26)5-1-2-12-28-22/h13-15,18H,1-12,16H2 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CNS BBB Library (22607 compounds)

CNS Targets (44014 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Nervous system
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with InChI=1S/C22H30F2N2O2/c23-19-13-17(14-20(24)15-19)16-25-8-3-18(4-9-25)21(27)26-10-6-22(7-11-26)5-1-2-12-28-22/h13-15,18H,1-12,16H2 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C22H30F2N2O2/c23-19-13-17(14-20(24)15-19)16-25-8-3-18(4-9-25)21(27)26-10-6-22(7-11-26)5-1-2-12-28-22/h13-15,18H,1-12,16H2?
Check Price and Availability of InChI=1S/C22H30F2N2O2/c23-19-13-17(14-20(24)15-19)16-25-8-3-18(4-9-25)21(27)26-10-6-22(7-11-26)5-1-2-12-28-22/h13-15,18H,1-12,16H2, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C22H30F2N2O2/c23-19-13-17(14-20(24)15-19)16-25-8-3-18(4-9-25)21(27)26-10-6-22(7-11-26)5-1-2-12-28-22/h13-15,18H,1-12,16H2 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C22H30F2N2O2/c23-19-13-17(14-20(24)15-19)16-25-8-3-18(4-9-25)21(27)26-10-6-22(7-11-26)5-1-2-12-28-22/h13-15,18H,1-12,16H2
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C22H30F2N2O2/c23-19-13-17(14-20(24)15-19)16-25-8-3-18(4-9-25)21(27)26-10-6-22(7-11-26)5-1-2-12-28-22/h13-15,18H,1-12,16H2
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C22H30F2N2O2/c23-19-13-17(14-20(24)15-19)16-25-8-3-18(4-9-25)21(27)26-10-6-22(7-11-26)5-1-2-12-28-22/h13-15,18H,1-12,16H2 available by request